@AlCp BCell - I wasn't expecting a deal (doesnt matter what I think) - only going off what LC was saying and projecting then. Deal or something in the next 12 monhts (you can see in video posted from 2018).
HerVaxx - yes completed a phase 2 - but they started two more phase 2's (next + neo Herizon) after this and spent millions$ on batches of hervaxx and recruited 7 patients - then moved on. I suspect the issue with the completed phase 2 hervaxx (herizon) results is not enough data - this is why they went for two more phase 2's and why it cant be sold now.
PD1 - Vaxx - Yes a new trial to start this year - that's the one that was announced in Dec 2023 as starting in 2024, right? O.k 14 months later - we will see.
Checkvacc - Yes it stopped because Vaxinia is so good - or maybe it stopped because it recruited nine patients over 2.5 years at one recruitment site (it was gonna take about 10 years to get through a phase 1).
Cf33 - Still waiting over 18 months - Now ask yourself why is that? Is there form in this area - or what.
(20min delay)